{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:29:28Z","timestamp":1793471368519,"version":"4.5.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T00:00:00Z","timestamp":1214438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s00592-008-0042-y","type":"journal-article","created":{"date-parts":[[2008,6,25]],"date-time":"2008-06-25T13:13:10Z","timestamp":1214399590000},"page":"131-141","source":"Crossref","is-referenced-by-count":107,"title":["Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications"],"prefix":"10.1007","volume":"45","author":[{"given":"Elena","family":"Beltramo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Berrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Tarallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,26]]},"reference":[{"key":"42_CR1","doi-asserted-by":"crossref","unstructured":"Jansen B, Donath W (1926) Geneeskundig Tijdschrift voor Nederlandsch-Indie 66:1\u20132 (Reprinted as (1982) The isolation of the anti beri beri vitamin. Nutr Rev 40:53\u201355)","DOI":"10.1111\/j.1753-4887.1982.tb05262.x"},{"key":"42_CR2","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s00018-007-6423-5","volume":"64","author":"RAW Frank","year":"2007","unstructured":"Frank RAW, Leeper FJ, Luisi BF (2007) Structure, mechanism and catalytic duality of thiamine-dependent enzymes. Cell Mol Life Sci 64:892\u2013905","journal-title":"Cell Mol Life Sci"},{"key":"42_CR3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S0029665199000567","volume":"58","author":"DA Bender","year":"1999","unstructured":"Bender DA (1999) Optimum nutrition: thiamin, biotin and pantothenate. Proc Nutr Soc 58:427\u2013433","journal-title":"Proc Nutr Soc"},{"key":"42_CR4","volume-title":"Biochemistry","author":"L Stryer","year":"1988","unstructured":"Stryer L (1988) Biochemistry. Freeman WH and Company, New York"},{"key":"42_CR5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/jnnp.42.3.226","volume":"42","author":"C Harper","year":"1979","unstructured":"Harper C (1979) Wernicke\u2019s encephalopathy, a more common disease than realised (a neuropathological study of 51 cases). J Neurol Neurosurg Psychol 42:226\u2013231","journal-title":"J Neurol Neurosurg Psychol"},{"key":"42_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/bcmd.2000.0356","volume":"27","author":"EJ Neufeld","year":"2001","unstructured":"Neufeld EJ, Fleming JC, Tartaglini E, Steinkamp MP (2001) Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport. Blood Cells Mol Dis 27:135\u2013138","journal-title":"Blood Cells Mol Dis"},{"key":"42_CR7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/alcalc\/35.Supplement_1.2","volume":"35","author":"AD Thomson","year":"2000","unstructured":"Thomson AD (2000) Mechanisms of vitamin deficiency in chronic alcohol misusers and the development of the Wernicke\u2013Korsakoff syndrome. Alcohol Alcohol Suppl 35:2\u20137","journal-title":"Alcohol Alcohol Suppl"},{"key":"42_CR8","first-page":"803","volume":"74","author":"ZG Abbas","year":"1997","unstructured":"Abbas ZG, Swai AB (1997) Evaluation of the efficacy of thiamine and pyridoxine in the treatment of symptomatic diabetic peripheral neuropathy. East Afr Med J 74:803\u2013808","journal-title":"East Afr Med J"},{"key":"42_CR9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2005.10.022","volume":"394","author":"S Wu","year":"2006","unstructured":"Wu S, Ren J (2006) Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha. Neurosci Lett 394:158\u2013162","journal-title":"Neurosci Lett"},{"key":"42_CR10","first-page":"701","volume":"99","author":"AM Hoyumpa Jr","year":"1982","unstructured":"Hoyumpa AM Jr, Strickland R, Sheehan JJ, Yarborough G, Nichols S (1982) Dual system of intestinal thiamine transport in humans. J Lab Clin Med 99:701\u2013708","journal-title":"J Lab Clin Med"},{"key":"42_CR11","first-page":"47","volume":"6","author":"G Rindi","year":"1984","unstructured":"Rindi G (1984) Thiamine absorption by small intestine. Acta Vitaminol Enzymol 6:47\u201355","journal-title":"Acta Vitaminol Enzymol"},{"key":"42_CR12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1525-1373.2000.22428.x","volume":"224","author":"G Rindi","year":"2000","unstructured":"Rindi G, Lafarenza U (2000) Thiamine intestinal transport and related issues: recent aspects. PSEBM 224:246\u2013255","journal-title":"PSEBM"},{"key":"42_CR13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02124072","volume":"33","author":"G Rindi","year":"1997","unstructured":"Rindi G, Ferrari G (1997) Thiamine transport by human intestine in vitro. Experientia 33:211\u2013213","journal-title":"Experientia"},{"key":"42_CR14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/ajcn\/66.2.320","volume":"66","author":"U Lafarenza","year":"1997","unstructured":"Lafarenza U, Patrini C, Alvisi C, Faelli A, Licandro A, Rindi G (1997) Thiamine uptake in human intestinal biopsy specimen, including observations from a patient with acute thiamine deficiency. Am J Clin Nutr 66:320\u2013326","journal-title":"Am J Clin Nutr"},{"key":"42_CR15","first-page":"100S","volume":"493","author":"C Patrini","year":"1996","unstructured":"Patrini C, Lafarenza U, Gastaldi G, Verri A, Ferrari G, Rindi G (1996) Effects of insulin on thiamine intestinal transport in rat everted jejunal sacs. J Physiol (Lond) 493:100S\u2013101S","journal-title":"J Physiol (Lond)"},{"key":"42_CR16","first-page":"129","volume":"27","author":"U Lafarenza","year":"1995","unstructured":"Lafarenza U, Gastaldi G, Verri A, Rindi G (1995) Effects of thyroid hormone and insulin on thiamine intestinal transport in vitro. Ital J Gastroenterol 27:129","journal-title":"Ital J Gastroenterol"},{"key":"42_CR17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5925\/jnsv1954.10.79","volume":"10","author":"M Fujimara","year":"1964","unstructured":"Fujimara M, Sasakawa S, Itokawa Y, Ikeda K (1964) Affinity of thiamine propyl disulfide-S35 to organs. J Vitaminol (Kyoto) 10:79\u201387","journal-title":"J Vitaminol (Kyoto)"},{"issue":"Suppl","key":"42_CR18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3177\/jnsv.22.Supplement_57","volume":"22","author":"M Fujimara","year":"1976","unstructured":"Fujimara M (1976) Allithiamine and its properties. J Nutr Sci Vitaminol (Tokyo) 22(Suppl):57\u201362","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"Suppl","key":"42_CR19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3177\/jnsv.22.Supplement_63","volume":"22","author":"H Baker","year":"1976","unstructured":"Baker H, Frank O (1976) Absorption, utilization and clinical effectiveness of allithiamines compared to water-soluble thiamines. J Nutr Sci Vitaminol (Tokyo) 22(Suppl):63\u201368","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"42_CR20","first-page":"216","volume":"36","author":"A Greb","year":"1998","unstructured":"Greb A, Bitsch R (1998) Comparative bioavailability of various thiamine derivatives after oral administration. Int J Clin Pharmacol Ther 36:216\u2013221","journal-title":"Int J Clin Pharmacol Ther"},{"key":"42_CR21","first-page":"319","volume":"52","author":"KH Schreeb","year":"1997","unstructured":"Schreeb KH, Freudenthaler S, Vormfelde SV, Gundert-Remy U, Gleiter CH (1997) Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate. Eur J Pharmacol 52:319\u2013320","journal-title":"Eur J Pharmacol"},{"key":"42_CR22","first-page":"47","volume":"34","author":"D Loew","year":"1996","unstructured":"Loew D (1996) Pharmacokinetics of thiamine derivatives especially of benfotiamine. Int J Clin Pharmacol Ther 34:47\u201350","journal-title":"Int J Clin Pharmacol Ther"},{"key":"42_CR23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2337\/diab.43.6.836","volume":"43","author":"M Brownlee","year":"1994","unstructured":"Brownlee M (1994) Glycation and diabetic complications. Diabetes 43:836\u2013841","journal-title":"Diabetes"},{"key":"42_CR24","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S1357-2725(98)00095-8","volume":"30","author":"G Schenk","year":"1998","unstructured":"Schenk G, Duggleby RG, Nixon PF (1998) Properties and functions of the thiamine diphosphate dependent enzyme transketolase. Int J Biochem Cell Biol 30:1297\u20131318","journal-title":"Int J Biochem Cell Biol"},{"key":"42_CR25","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.2337\/diabetes.52.8.2110","volume":"52","author":"R Babaei-Jadidi","year":"2003","unstructured":"Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ (2003) Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 52:2110\u20132120","journal-title":"Diabetes"},{"key":"42_CR26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/oxfordjournals.jbchem.a002889","volume":"129","author":"PJ Thornalley","year":"2001","unstructured":"Thornalley PJ, Jahan I, Ng R (2001) Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. J Biochem 129:543\u2013549","journal-title":"J Biochem"},{"key":"42_CR27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nm834","volume":"9","author":"HP Hammes","year":"2003","unstructured":"Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M (2003) Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 9:294\u2013299","journal-title":"Nat Med"},{"key":"42_CR28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0009-8981(90)90072-Z","volume":"192","author":"PF Nixon","year":"1990","unstructured":"Nixon PF, Price J, Norman-Hick M, Williams GM, Kerr RA (1990) The relationship between erythrocyte transketolase activity and the \u201cTPP effect\u201d in Wernicke\u2019s encephalopathy and other thiamine deficiency states. Clin Chim Acta 192:89\u201398","journal-title":"Clin Chim Acta"},{"key":"42_CR29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jn\/37.4.411","volume":"37","author":"MK Horwitt","year":"1949","unstructured":"Horwitt MK, Kreisler O (1949) The determination of early thiamine deficient states by estimation of blood lactate and pyruvate after glucose administration and exercise. J Nutr 37:411\u2013427","journal-title":"J Nutr"},{"key":"42_CR30","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1530-0277.1993.tb05668.x","volume":"17","author":"RF Butterworth","year":"1993","unstructured":"Butterworth RF, Kril JJ, Harper CG (1993) Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke\u2013Korsakoff syndrome. Alcohol Clin Exp Res 17:1084\u20131088","journal-title":"Alcohol Clin Exp Res"},{"key":"42_CR31","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DCCT: The Diabetes Control and Complications Trial Research Group","year":"1993","unstructured":"DCCT: The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977\u2013986","journal-title":"N Engl J Med"},{"key":"42_CR32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study Group","year":"1998","unstructured":"UK Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837\u2013853","journal-title":"Lancet"},{"key":"42_CR33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2337\/diab.42.1.80","volume":"42","author":"N Kaiser","year":"1993","unstructured":"Kaiser N, Sasson S, Feener EP, Boukobza-Vardi N, Higashi S, Moller DE, Davidheiser S, Przybylski RJ, King GL (1993) Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 42:80\u201389","journal-title":"Diabetes"},{"key":"42_CR34","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1172\/JCI118226","volume":"96","author":"CW Heilig","year":"1995","unstructured":"Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, Cortes P (1995) Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96:1802\u20131814","journal-title":"J Clin Invest"},{"key":"42_CR35","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI118563","volume":"97","author":"I Giardino","year":"1996","unstructured":"Giardino I, Edelstein D, Brownlee M (1996) Bcl-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation end products in bovine endothelial cells. J Clin Invest 97:1422\u20131428","journal-title":"J Clin Invest"},{"key":"42_CR36","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1046\/j.1523-1755.2000.07705.x","volume":"58","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Edelstein D, Brownlee M (2000) The missing link: a single unifying mechanism for diabetic complications. Kidney Int 58:S26\u2013S30","journal-title":"Kidney Int"},{"key":"42_CR37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1677\/joe.0.1580021","volume":"158","author":"E Brignardello","year":"1998","unstructured":"Brignardello E, Beltramo E, Molinatti PA, Aragno M, Gatto V, Tamagno E, Danni O, Porta M, Boccuzzi G (1998) Dehydroepiandrosterone protects bovine retinal capillary pericytes against glucose toxicity. J Endocrinol 158:21\u201326","journal-title":"J Endocrinol"},{"key":"42_CR38","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0002-9440(10)64970-X","volume":"156","author":"F Podest\u00e0","year":"2000","unstructured":"Podest\u00e0 F, Romeo G, Liu WH, Krajewski S, Reed JC, Gerhardinger C, Lorenzi M (2000) Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol 156:1025\u20131032","journal-title":"Am J Pathol"},{"key":"42_CR39","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/dmrr.470","volume":"20","author":"E Beltramo","year":"2004","unstructured":"Beltramo E, Berrone E, Buttiglieri S, Porta M (2004) Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose. Diabetes Metab Res Rev 20:330\u2013336","journal-title":"Diabetes Metab Res Rev"},{"key":"42_CR40","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2337\/diabetes.50.10.2363","volume":"50","author":"F Fiordaliso","year":"2001","unstructured":"Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P, Kaistura J (2001) Hyperglycemia activates p53 and p53-regulated denes leading to myocyte cell death. Diabetes 50:2363\u20132375","journal-title":"Diabetes"},{"key":"42_CR41","doi-asserted-by":"crossref","first-page":"F455","DOI":"10.1152\/ajprenal.00137.2002","volume":"284","author":"BP Kang","year":"2003","unstructured":"Kang BP, Frencher S, Reddy V, Kessler A, Malhotra A, Meggs LG (2003) High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism. Am J Physiol Renal Physiol 284:F455\u2013F466","journal-title":"Am J Physiol Renal Physiol"},{"key":"42_CR42","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1096\/fj.04-2513fje","volume":"19","author":"AM Vincent","year":"2005","unstructured":"Vincent AM, McLean LL, Backus C, Feldman EL (2005) Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J 19:638\u2013640","journal-title":"FASEB J"},{"key":"42_CR43","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/labinvest.3700418","volume":"86","author":"T Khera","year":"2006","unstructured":"Khera T, Martin J, Riley S, Steadman R, Phillips AO (2006) Glucose enhances mesangial cell apoptosis. Lab Invest 86:566\u2013577","journal-title":"Lab Invest"},{"key":"42_CR44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2337\/diabetes.55.01.06.db05-0894","volume":"55","author":"K Sustzak","year":"2006","unstructured":"Sustzak K, Raff AC, Schiffer M, B\u00f6ttinger EP (2006) Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55:225\u2013231","journal-title":"Diabetes"},{"key":"42_CR45","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.2337\/diabetes.51.7.2241","volume":"51","author":"G Romeo","year":"2002","unstructured":"Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M (2002) Activation of nuclear factor-kappa B induced by diabetes and high glucose regulates a pro-apoptotic program in retinal pericytes. Diabetes 51:2604\u20132611","journal-title":"Diabetes"},{"key":"42_CR46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF00403300","volume":"39","author":"W Li","year":"1996","unstructured":"Li W, Liu X, Yanoff M, Cohen S, Ye X (1996) Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells. Diabetologia 39:537\u2013547","journal-title":"Diabetologia"},{"key":"42_CR47","first-page":"1535","volume":"39","author":"W Li","year":"1998","unstructured":"Li W, Liu X, He Z, Yanoff M, Jian B, Ye X (1998) Expression of apoptosis regulatory genes by retinal pericytes after rapid glucose reduction. IOVS 39:1535\u20131543","journal-title":"IOVS"},{"key":"42_CR48","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00125-007-0684-2","volume":"50","author":"MA Ihnat","year":"2007","unstructured":"Ihnat MA, Thorpe JE, Kamat CD, Szab\u00f3 C, Green DE, Warnke LA, Lacza Z, Cseleny\u00e1k A, Ross K, Shakir S, Piconi L, Kaltreider RC, Ceriello A (2007) Reactive oxygen species mediate a cellular \u201cmemory\u201d of high glucose stress signalling. Diabetologia 50:1523\u20131531","journal-title":"Diabetologia"},{"key":"42_CR49","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1172\/JCI113655","volume":"82","author":"E Cagliero","year":"1988","unstructured":"Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M (1988) Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest 82:735\u2013738","journal-title":"J Clin Invest"},{"key":"42_CR50","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1073\/pnas.87.1.404","volume":"87","author":"S Roy","year":"1990","unstructured":"Roy S, Sala R, Cagliero E, Lorenzi M (1990) Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 87:404\u2013408","journal-title":"Proc Natl Acad Sci USA"},{"key":"42_CR51","doi-asserted-by":"crossref","first-page":"E924","DOI":"10.1152\/ajpendo.2001.281.5.E924","volume":"281","author":"A Risso","year":"2001","unstructured":"Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A (2001) Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 281:E924\u2013E930","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"42_CR52","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.2337\/diabetes.52.11.2795","volume":"52","author":"L Quagliaro","year":"2003","unstructured":"Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A (2003) Intermittent high glucose enhances apoptosis relate to oxidative stress in human umbilical vein endothelial cells. Diabetes 52:2795\u20132804","journal-title":"Diabetes"},{"key":"42_CR53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/dmrr.613","volume":"22","author":"L Piconi","year":"2006","unstructured":"Piconi L, Quagliaro L, Assaloni R, Da Ros R, Maier A, Zuodar G, Ceriello A (2006) Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diab Met Res Rev 22:198\u2013203","journal-title":"Diab Met Res Rev"},{"key":"42_CR54","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jdiacomp.2004.03.002","volume":"18","author":"RA Kowluru","year":"2004","unstructured":"Kowluru RA, Abbas SN, Odenbach S (2004) Reversal of hyperglycemia and diabetic nephropathy: effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats. J Diabet Complications 18:282\u2013288","journal-title":"J Diabet Complications"},{"key":"42_CR55","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s001250100020","volume":"44","author":"E Bonora","year":"2001","unstructured":"Bonora E, Muggeo M (2001) Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia 44:2107\u20132114","journal-title":"Diabetologia"},{"issue":"suppl.2","key":"42_CR56","first-page":"B21","volume":"23","author":"M Shichiri","year":"2000","unstructured":"Shichiri M, Kishikawa H, Ohkubo Y, Wake N (2000) Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23(suppl.2):B21\u2013B29","journal-title":"Diabetes Care"},{"key":"42_CR57","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2337\/diacare.7.3.236","volume":"7","author":"E Ballegooie Van","year":"1984","unstructured":"Van Ballegooie E, Hooymans JM, Timmerman Z, Reitsma WD, Sluiter WJ, Schweitzer NM, Doorenbos H (1984) Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care 7:236\u2013242","journal-title":"Diabetes Care"},{"key":"42_CR58","first-page":"885","volume":"290","author":"P Dandona","year":"1985","unstructured":"Dandona P, Bolger JP, Boag F, Fonesca V, Abrams JD (1985) Rapid development and progression of proliferative retinopathy after strict diabetic control. BMJ 290:885\u2013896","journal-title":"BMJ"},{"key":"42_CR59","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/bmj.290.6471.811","volume":"290","author":"K Dahl-Jorgensen","year":"1985","unstructured":"Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenages O (1985) Rapid tightening of blood glucose levels leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus. BMJ 290:811\u2013815","journal-title":"BMJ"},{"key":"42_CR60","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2337\/diab.36.7.808","volume":"36","author":"RL Engerman","year":"1987","unstructured":"Engerman RL, Kern TS (1987) Progression of incipient diabetic retinopathy during good glycaemic control. Diabetes 36:808\u2013812","journal-title":"Diabetes"},{"key":"42_CR61","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/diab.42.6.801","volume":"42","author":"JR Williamson","year":"1993","unstructured":"Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Van Den Enden M, Kilo C, Tilton RG (1993) Hyperglycemic pseudoypoxia and diabetic complications. Diabetes 42:801\u2013813","journal-title":"Diabetes"},{"key":"42_CR62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1096\/fasebj.13.1.23","volume":"13","author":"AY Lee","year":"1999","unstructured":"Lee AY, Chung SS (1999) Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J 13:23\u201330","journal-title":"FASEB J"},{"key":"42_CR63","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813\u2013820","journal-title":"Nature"},{"key":"42_CR64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s001250050084","volume":"37","author":"RL Engerman","year":"1994","unstructured":"Engerman RL, Kern TS, Larson ME (1994) Nerve conduction and aldose reductase inhibition during 5\u00a0years of diabetes or galactosaemia in dogs. Diabetologia 37:141\u2013144","journal-title":"Diabetologia"},{"key":"42_CR65","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/diab.40.4.405","volume":"40","author":"JW Baynes","year":"1991","unstructured":"Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405\u2013412","journal-title":"Diabetes"},{"key":"42_CR66","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1172\/JCI117296","volume":"94","author":"I Giardino","year":"1994","unstructured":"Giardino I, Edelstein D, Brownlee M (1994) Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J Clin Invest 94:110\u2013117","journal-title":"J Clin Invest"},{"key":"42_CR67","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2337\/diab.39.7.807","volume":"39","author":"AS Charonis","year":"1990","unstructured":"Charonis AS, Reger LA, Dege JE, Kouzi-Koliakos K, Furcht LT, Wohlhueter RM, Tsilibary EC (1990) Laminin alterations after in vitro nonenzymatic glycosylation. Diabetes 39:807\u2013814","journal-title":"Diabetes"},{"key":"42_CR68","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s00125-001-0761-x","volume":"45","author":"E Beltramo","year":"2002","unstructured":"Beltramo E, Pomero F, Allione A, D\u2019Al\u00f9 F, Ponte E, Porta M (2002) Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations. Diabetologia 45:416\u2013419","journal-title":"Diabetologia"},{"key":"42_CR69","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00125-003-1043-6","volume":"46","author":"E Beltramo","year":"2003","unstructured":"Beltramo E, Buttiglieri S, Pomero F, Allione A, D\u2019Al\u00f9 F, Ponte E, Porta M (2003) A study of capillary pericyte viability on extracellular matrix produced by endothelial cells in high glucose. Diabetologia 46:409\u2013415","journal-title":"Diabetologia"},{"key":"42_CR70","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1073\/pnas.89.7.2873","volume":"89","author":"T Doi","year":"1992","unstructured":"Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ (1992) Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 89:2873\u20132877","journal-title":"Proc Natl Acad Sci USA"},{"key":"42_CR71","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI118175","volume":"96","author":"AM Schmidt","year":"1995","unstructured":"Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D (1995) Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96:1395\u20131403","journal-title":"J Clin Invest"},{"key":"42_CR72","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1084\/jem.174.4.931","volume":"174","author":"EY Skolnik","year":"1991","unstructured":"Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H (1991) Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174:931\u2013939","journal-title":"J Exp Med"},{"key":"42_CR73","doi-asserted-by":"crossref","first-page":"11555","DOI":"10.1073\/pnas.88.24.11555","volume":"88","author":"HP Hammes","year":"1991","unstructured":"Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M (1991) Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88:11555\u201311558","journal-title":"Proc Natl Acad Sci USA"},{"key":"42_CR74","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2337\/diabetes.47.6.859","volume":"47","author":"D Koya","year":"1998","unstructured":"Koya D, King GL (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47:859\u2013866","journal-title":"Diabetes"},{"key":"42_CR75","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI119503","volume":"100","author":"D Koya","year":"1997","unstructured":"Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL (1997) Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115\u2013126","journal-title":"J Clin Invest"},{"key":"42_CR76","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","volume":"404","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787\u2013790","journal-title":"Nature"},{"key":"42_CR77","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.272.5262.728","volume":"272","author":"H Ishii","year":"1996","unstructured":"Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL (1996) Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272:728\u2013731","journal-title":"Science"},{"key":"42_CR78","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1096\/fasebj.14.3.439","volume":"14","author":"D Koya","year":"2000","unstructured":"Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R (2000) Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db\/db mice, a rodent model for type 2 diabetes. FASEB J 14:439\u2013447","journal-title":"FASEB J"},{"key":"42_CR79","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1046\/j.1523-1755.2000.07703.x","volume":"77","author":"ED Schleicher","year":"2000","unstructured":"Schleicher ED, Weigert C (2000) Role of the hexosamine biosyntetic pathway in diabetic nephropaty. Kidney Int 77:S13\u2013S18","journal-title":"Kidney Int"},{"key":"42_CR80","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.1073\/pnas.97.22.12222","volume":"97","author":"XL Du","year":"2000","unstructured":"Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 97:12222\u201312226","journal-title":"Proc Natl Acad Sci USA"},{"key":"42_CR81","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2337\/diabetes.53.3.762","volume":"53","author":"FR DeRubertis","year":"2004","unstructured":"DeRubertis FR, Craven PA, Melhem MF, Salah EM (2004) Attenuation of renal injury in db\/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. Diabetes 53:762\u2013768","journal-title":"Diabetes"},{"key":"42_CR82","first-page":"341","volume":"108","author":"X Du","year":"2003","unstructured":"Du X, Matsumura T, Edelstein D, Rossetti L, Zsengell\u00e9r Z, Szab\u00f3 C, Brownlee M (2003) Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 108:341\u20131057","journal-title":"J Clin Invest"},{"key":"42_CR83","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s001250050568","volume":"39","author":"M La Selva","year":"1996","unstructured":"La Selva M, Beltramo E, Pagnozzi F, Bena E, Molinatti PA, Molinatti GM, Porta M (1996) Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia 39:1263\u20131268","journal-title":"Diabetologia"},{"key":"42_CR84","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/bbrc.1996.0366","volume":"220","author":"AA Booth","year":"1996","unstructured":"Booth AA, Khalifah RG, Hudson BG (1996) Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine. Biochem Biophis Res Commun 220:113\u2013119","journal-title":"Biochem Biophis Res Commun"},{"key":"42_CR85","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/oxfordjournals.jbchem.a002889","volume":"129","author":"PJ Thornalley","year":"2001","unstructured":"Thornalley PJ, Jahan I, Ng R (2001) Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. Jpn J Biochem 129:543\u2013549","journal-title":"Jpn J Biochem"},{"key":"42_CR86","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s005920170010","volume":"38","author":"F Pomero","year":"2001","unstructured":"Pomero F, Molinar Min A, La Selva M, Allione A, Molinatti GM, Porta M (2001) Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose. Acta Diabetol 38:135\u2013138","journal-title":"Acta Diabetol"},{"key":"42_CR87","first-page":"741","volume":"40","author":"SJ Bakker","year":"1997","unstructured":"Bakker SJ, Heine RJ, Gans RO (1997) Thiamine may indirectly act as an antioxidant. Diabetologia 40:741\u2013742","journal-title":"Diabetologia"},{"key":"42_CR88","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3181\/00379727-104-25771","volume":"104","author":"GM Hsu","year":"1960","unstructured":"Hsu GM, Chow BF (1960) Effect of thiamine deficiency on glutathione contents of erythrocytes and tissues in the rat. Proc Soc Exp Biol Med 104:178\u2013180","journal-title":"Proc Soc Exp Biol Med"},{"key":"42_CR89","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","volume":"44","author":"R Singh","year":"2001","unstructured":"Singh R, Barden A, Mori T, Beilin L (2001) Advanced glycation end-products: a review. Diabetologia 44:129\u2013146","journal-title":"Diabetologia"},{"key":"42_CR90","doi-asserted-by":"crossref","first-page":"9307","DOI":"10.1074\/jbc.M600418200","volume":"281","author":"E Berrone","year":"2006","unstructured":"Berrone E, Beltramo E, Solimine C, Ape AU, Porta M (2006) Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. J Biol Chem 281:9307\u20139313","journal-title":"J Biol Chem"},{"key":"42_CR91","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1067\/msy.2001.117194","volume":"130","author":"E Ascher","year":"2001","unstructured":"Ascher E, Gade PV, Hingorani A, Puthukkeril S, Kallakuri S, Scheinman M, Jacob T (2001) Thiamine reverses hyperglycemia-induced dysfunctions in cultured endothelial cells. Surgery 130:851\u2013858","journal-title":"Surgery"},{"key":"42_CR92","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00125-005-0103-5","volume":"49","author":"S Gadau","year":"2006","unstructured":"Gadau S, Emanueli C, Van Linthout S, Graiani G, Todaro M, Meloni M, Campesi I, Invernici G, Spillmann F, Ward K, Madeddu P (2006) Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B\/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis. Diabetologia 49:405\u2013420","journal-title":"Diabetologia"},{"key":"42_CR93","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2337\/db06-0369","volume":"55","author":"V Marchetti","year":"2006","unstructured":"Marchetti V, Menghini R, Rizza S, Vivanti A, Feccia T, Lauro D, Fukamizu A, Lauro R, Federici M (2006) Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt\/FoxO signaling. Diabetes 55:2231\u20132237","journal-title":"Diabetes"},{"key":"42_CR94","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-2001-17399","volume":"109","author":"H Stracke","year":"2001","unstructured":"Stracke H, Hammes HP, Werkmann D, Mavrakis K, Bitsch I, Netzel M, Geyer J, K\u00f6pcke W, Sauerland C, Bretzel RG, Federlin KF (2001) Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp Clin Endocrinol Diabetes 109:330\u2013336","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"42_CR95","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1152\/japplphysiol.00988.2005","volume":"100","author":"AF Ceylan-Isik","year":"2006","unstructured":"Ceylan-Isik AF, Wu S, Li Q, Li SY, Ren J (2006) High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus. J Appl Physiol 100:150\u2013156","journal-title":"J Appl Physiol"},{"key":"42_CR96","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s00125-004-1582-5","volume":"47","author":"R Babaei-Jadidi","year":"2004","unstructured":"Babaei-Jadidi R, Karachalias N, Kupich C, Ahmed N, Thornalley PJ (2004) High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats. Diabetologia 47:2235\u20132246","journal-title":"Diabetologia"},{"key":"42_CR97","first-page":"461","volume":"48","author":"R Hilbig","year":"1998","unstructured":"Hilbig R, Rahmann H (1998) Comparative autoradiographic investigations on the tissue distribution of benfotiamine versus thiamine in mice. Arzneimittelforschung 48:461\u2013468","journal-title":"Arzneimittelforschung"},{"key":"42_CR98","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00592-006-0223-5","volume":"43","author":"A Yenilmez","year":"2006","unstructured":"Yenilmez A, Oz\u00e7if\u00e7i M, Aydin Y, Turgut M, Uzuner K, Erkul A (2006) Protective effect of high-dose thiamine (B1) on rat detrusor contractility in streptozotocin-induced diabetes mellitus. Acta Diabetol 43:103\u2013108","journal-title":"Acta Diabetol"},{"key":"42_CR99","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002280000131","volume":"56","author":"T Frank","year":"2000","unstructured":"Frank T, Bitsch R, Maiwald J, Stein G (2000) High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfotiamine. Eur J Clin Pharmacol 56:251\u2013257","journal-title":"Eur J Clin Pharmacol"},{"key":"42_CR100","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/alcalc\/33.6.631","volume":"33","author":"H Woelk","year":"1998","unstructured":"Woelk H, Lehrl S, Bitsch R, Kopcke W (1998) Benfotiamine in treatment of alcoholic polyneuropathy: an 8-week randomized controlled study (BAPI Study). Alcohol Alcohol 33:631\u2013638","journal-title":"Alcohol Alcohol"},{"key":"42_CR101","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-0029-1211460","volume":"104","author":"H Stracke","year":"1996","unstructured":"Stracke H, Lindemann A, Federlin K (1996) A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy. Exp Clin Endocrinol Diabetes 104:311\u2013316","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"42_CR102","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5414\/CPP43071","volume":"43","author":"E Haupt","year":"2005","unstructured":"Haupt E, Ledermann H, Kopcke W (2005) Benfotiamine in the treatment of diabetic polyneuropathy\u2014a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther 43:71\u201377","journal-title":"Int J Clin Pharmacol Ther"},{"key":"42_CR103","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3177\/jnsv.33.421","volume":"33","author":"N Saito","year":"1987","unstructured":"Saito N, Kimura M, Kuchiba A, Itokawa Y (1987) Blood thiamine levels in outpatients with diabetes mellitus. J Nutr Sci Vitaminol 33:421\u2013430","journal-title":"J Nutr Sci Vitaminol"},{"key":"42_CR104","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s005920050148","volume":"36","author":"G Valerio","year":"1999","unstructured":"Valerio G, Franzese A, Poggi V, Patrini C, Laforenza U, Tenore A (1999) Lipophilic thiamine treatment in long-standing insulin-dependent diabetes mellitus. Acta Diabetol 36:73\u201376","journal-title":"Acta Diabetol"},{"key":"42_CR105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3132\/dvdr.2006.014","volume":"3","author":"G Jermendy","year":"2006","unstructured":"Jermendy G (2006) Evaluating thiamine deficiency in patients with diabetes. Diab Vasc Dis Res 3:120\u2013121","journal-title":"Diab Vasc Dis Res"},{"key":"42_CR106","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1007\/s00125-007-0771-4","volume":"50","author":"PJ Thornalley","year":"2007","unstructured":"Thornalley PJ, Babaei-Jadidi R, Al Ali H, Rabbani N, Antonysunil A, Larkin J, Ahmed A, Rayman G, Bodmer CW (2007) High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 50:2164\u20132170","journal-title":"Diabetologia"},{"key":"42_CR107","first-page":"1409","volume":"62","author":"II Stepuro","year":"1997","unstructured":"Stepuro II, Piletskaya TP, Stepuro VI, Maskevich SA (1997) Thiamine oxidative transformations catalyzed by copper ions and ascorbic acid. Biochemistry 62:1409\u20131414","journal-title":"Biochemistry"},{"key":"42_CR108","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.2337\/dc06-0531","volume":"29","author":"A Stirban","year":"2006","unstructured":"Stirban A, Negrean M, Stratmann B, Gawlowski T, Horstmann T, G\u00f6tting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D (2006) Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 29:2064\u20132071","journal-title":"Diabetes Care"},{"key":"42_CR109","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/S10016-006-9055-6","volume":"20","author":"S Arora","year":"2006","unstructured":"Arora S, Lidor A, Abularrage CJ, Weiswasser JM, Nylen E, Kellicut D, Sidawy AN (2006) Thiamine (vitamin B1) improves endothelium-dependent vasodilatation in the presence of hyperglycemia. Ann Vasc Surg 20:653\u2013658","journal-title":"Ann Vasc Surg"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-008-0042-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-008-0042-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-008-0042-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T03:45:14Z","timestamp":1559101514000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-008-0042-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,26]]},"references-count":109,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["42"],"URL":"https:\/\/doi.org\/10.1007\/s00592-008-0042-y","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,26]]}}}